Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: An observational study.

ABSTRACT:

Background

Lidocaine and amiodarone are both included in the pediatric cardiac arrest guidelines as treatments of shock-refractory ventricular fibrillation or pulseless ventricular tachycardia, although there is limited evidence to support this recommendation.

Methods

In this cohort study from the Get With The Guidelines - Resuscitation registry, we included pediatric patients (≤18 years) with an in-hospital cardiac arrest between 2000 and 2018, who presented with an initial or subsequent shockable rhythm (ventricular fibrillation and pulseless ventricular tachycardia). Patients receiving amiodarone were matched to patients receiving lidocaine based on a propensity score, calculated from multiple patient, event, and hospital characteristics.

Results

A total of 365 pat

SUBMITTER: Holmberg MJ 

PROVIDER: S-EPMC10416093 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature